Pfizer Escapes Whistleblower Suit Over Lipitor Marketing

Law360, New York (January 22, 2014, 5:42 PM EST) -- Health Support Awareness Inc. is dropping its whistleblower suit in Massachusetts federal court against Pfizer Inc. over the pharmaceutical giant's marketing of its cholesterol drug Lipitor after the U.S. government declined to intervene in the case, the U.S. attorney's office announced Wednesday.

The U.S. attorney's office on Wednesday consented to the dismissal of Health Support Awareness's qui tam suit against Pfizer, court documents showed. Health Support Awareness had moved to voluntarily dismiss the suit after the U.S. attorney's office declined to intervene in the case, according to the nonprofit's motion dated January 16.

The motion for dismissal came just over a...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!